Recent breakthroughs in innovative elements, multidimensional enhancements, derived technologies, and novel applications of PROTACs

Proteolysis Targeting Chimera (PROTAC) is an emerging and evolving technology based on targeted protein degradation (TPD). Small molecule PROTACs have shown great efficacy in degrading disease-specific proteins in preclinical and clinical studies, but also showed various limitations. In recent years...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 180; p. 117584
Main Authors Zhang, Si-Han, Zeng, Na, Xu, Jin-Zhou, Liu, Chen-Qian, Xu, Meng-Yao, Sun, Jian-Xuan, An, Ye, Zhong, Xing-Yu, Miao, Lin-Tao, Wang, Shao-Gang, Xia, Qi-Dong
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.11.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Proteolysis Targeting Chimera (PROTAC) is an emerging and evolving technology based on targeted protein degradation (TPD). Small molecule PROTACs have shown great efficacy in degrading disease-specific proteins in preclinical and clinical studies, but also showed various limitations. In recent years, new technologies and advances in TPD have provided additional optimized strategies based on conventional PROTACs that can overcome the shortcomings of conventional PROTACs in terms of undruggable targets, bioavailability, tissue-specificity, spatiotemporal control, and degradation scope. In addition, some designs of special targeting chimeras and applications based on multidisciplinary science have shed light on novel therapeutic modalities and drug design. However, each improvement has its own advantages, disadvantages and application conditions. In this review, we summarize the exploration of PROTAC elements, depict a landscape of improvements and derived concepts of PROTACs, and expect to provide perspectives for technological innovations, combinations and applications in future targeting chimera design. [Display omitted] •Rapid advancements in PROTAC development include innovative warhead, linker, and E3 ligase ligand designs.•Strategies like nanomedicine, spatiotemporal control, and computer-aided design enhance PROTAC potency.•Integrating multidisciplinary technologies rationally could lead to more potent and safer PROTACs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0753-3322
1950-6007
1950-6007
DOI:10.1016/j.biopha.2024.117584